Built at the Internet Archive
Collection Name
Sort By:
Creator
Sort By:
Sites and collections from this organization are listed below. Narrow your results at left, or enter a search query below to find a collection, site, specific URL or to search the text of archived webpages.
Page 1 of 1 (2 Total Results)
Sort By:
Collection: Mount Sinai Institutions
Description: This site documents the activities of the Precision Immunology Institute at the Icahn School of Medicine (PrIISM) during the COVID-19 pandemic. PrIISM faculty, led by the institute’s Director, Dr. Miriam Merad, immediately began dedicated scientific studies aimed at finding better ways to treat COVID-19 and reduce the mortality rate of the disease. This includes comprehensive studies of the blood, cells, and tissues of infected patients and work towards novel or repurposed therapies and vaccines to treat COVID-19. The PrIISM team also worked to understand why some people, including some children, develop more severe COVID, how to treat people better to reduce disease severity, and to identify the factors that cause long COVID, in which some individuals retain disease symptoms for months after initial infection.
Loading Wayback Capture Info...
Loading video data...
Subject: COVID-19--Immunology, COVID-19 Vaccines, Post-Acute COVID-19 Syndrome
Group: COVID-19
Creator: Icahn School of Medicine at Mount Sinai. Precision Immunology Institute
Source: Description based on archived website. Last updated January 2023.
Language: English
Format: 1 archived website
Type: website
Date: 2023-
Rights: ©2023 Icahn School of Medicine at Mount Sinai
Collector: Arthur H. Aufses, Jr. MD Archives
Collection: Mount Sinai Health System and COVID-19
Description: This site documents the activities of the Precision Immunology Institute at the Icahn School of Medicine (PrIISM) during the COVID-19 pandemic. PrIISM faculty, led by the institute’s Director, Dr. Miriam Merad, immediately began dedicated scientific studies aimed at finding better ways to treat COVID-19 and reduce the mortality rate of the disease. This includes comprehensive studies of the blood, cells, and tissues of infected patients and work towards novel or repurposed therapies and vaccines to treat COVID-19. The PrIISM team also worked to understand why some people, including some children, develop more severe COVID, how to treat people better to reduce disease severity, and to identify the factors that cause long COVID, in which some individuals retain disease symptoms for months after initial infection.
Loading Wayback Capture Info...
Loading video data...
Subject: COVID-19--Immunology, COVID-19 Vaccines, Post-Acute COVID-19 Syndrome
Group: COVID-19
Creator: Icahn School of Medicine at Mount Sinai. Precision Immunology Institute
Source: Description based on archived website. Last updated January 2023.
Language: English
Format: 1 archived website
Type: website
Date: 2023-
Rights: ©2023 Icahn School of Medicine at Mount Sinai
Collector: Arthur H. Aufses, Jr. MD Archives
Page 1 of 1 (2 Total Results)
